Nath Bio-Genes (India) EV/EBITDA Ratio

Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio

The Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Nath Bio-Genes (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Nath Bio-Genes (India) Ltd (NSE: NATHBIOGEN, BSE: 537291) is currently trading at ₹146.78, with a market capitalization of ₹2.82B. As a leading company in the Process industries sector and Agricultural commodities/Milling industry, monitoring the Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio Current Value

The current Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio stands at 5.98.

The Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

• 2024: 5.98
• 2023: 7.13
• 2022: 6.76
• 2021: 12.73
• 2020: 9.36

The decline in Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Nath Bio-Genes (India) Ltd.

Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Nath Bio-Genes (India) Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.